Maida Ranjbar

Brachytherapy (BT) remains the standard modality for dose escalation in cervical cancer boost targets, with well-established high-dose-rate (HDR) EQD2 constraints based on HR-CTV D90 and organ-at-risk (OAR) D2cc metrics. However, BT is not feasible for all pa...

This study evaluates a commercial web-based AI model for auto-segmentation of pelvic sites by comparing its contours to expert ground truth and an alternative AI model, emphasizing its accuracy and clinical relevance for radiotherapy planning.